Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (815) Renal Failure
...Renal Failure Country • [X]   China China Beijing : Research Site: A Study of Torasemide Compared With Furosemide in Patients With Renal Failure or Nephrotic Syndrome Guangzhou : Research Site: A Study of Torasemide Compared With Furosemide in Patients With Renal Failure or Nephrotic Syndrome Shanghai : Research Site: A Study of Torasemide ...
View Page

2. Clinical Trial Results by Drug Names
...Study: An open-label, randomized, multicenter study to assess diuresis and safety of torasemide versus furosemide in the treatment of patients with acute/chronic renal failure or nephrotic syndrome. Fast Facts ...
...nephrotic syndrome, to investigate the efficacy and safety of Torem (torasemide) compared to that of furosemide. Study center(s) : 6 centers in China. Objectives: Primary: To compare the diuretic effect and ...
View Page

3.  Study Posting (4519) Trial #126403, Renal Failure, Shanghai, China
...4519) Trial #126403, Renal Failure, Shanghai, China Trial Information A Study of Torasemide Compared With Furosemide in Patients With Renal Failure or Nephrotic Syndrome Status: Completed Protocol Number: ML18113 Sponsor: Shanghai ...
...Title: An open-label, randomized, multicenter study to assess diuresis and safety of torasemide versus furosemide in the treatment of patients with acute/chronic renal failure or nephrotic syndrome Brief Summary ...
View Page

4.  Study Posting (4519) Trial #126439, Renal Failure, Guangzhou, China
...4519) Trial #126439, Renal Failure, Guangzhou, China Trial Information A Study of Torasemide Compared With Furosemide in Patients With Renal Failure or Nephrotic Syndrome Status: Completed Protocol Number: ML18113 Sponsor: Shanghai ...
...Title: An open-label, randomized, multicenter study to assess diuresis and safety of torasemide versus furosemide in the treatment of patients with acute/chronic renal failure or nephrotic syndrome Brief Summary ...
View Page

5.  Study Posting (4519) Trial #126402, Renal Failure, Beijing, China
...4519) Trial #126402, Renal Failure, Beijing, China Trial Information A Study of Torasemide Compared With Furosemide in Patients With Renal Failure or Nephrotic Syndrome Status: Completed Protocol Number: ML18113 Sponsor: Shanghai ...
...Title: An open-label, randomized, multicenter study to assess diuresis and safety of torasemide versus furosemide in the treatment of patients with acute/chronic renal failure or nephrotic syndrome Brief Summary ...
View Page

6. Clinical Trial Results: Renal Failure
...III An open-label, randomized, multicenter study to assess diuresis and safety of torasemide versus furosemide in the treatment of patients with acute/chronic renal failure or nephrotic syndrome. Jobson Medical ...
View Page

7. Advanced/Specific Search Results Torem [torasemide]
...III An open-label, randomized, multicenter study to assess diuresis and safety of torasemide versus furosemide in the treatment of patients with acute/chronic renal failure or nephrotic syndrome. Jobson Medical ...
View Page

8.  News: NovaCardia Sees Positive Results with treatment for heart failure (Clinical Trials Today)
...of intravenous KW- 3902, administered daily for up to three days. All subjects received intravenous furosemide. The primary endpoint was the proportion of subjects in the categories of treatment success, treatment ...
View Page

9.  CenterWatch: New Medical Therapies in Disease Category (162), Congestive Heart Failure
...two-way crossover trial enrolled 32 stable CHF subjects with mild renal impairment. Subjects received furosemide with KW-3902 or furosemide with placebo. Data demonstrated that over an eight hour period, KW-3902 provided an increase ...
View Page

10.  CenterWatch: New Medical Therapies in Disease Category (281), Heart Failure
...milligramdoses of intravenous KW-3902, administered daily for up to three days. All subjectsreceived intravenous furosemide. The primary endpoint was the proportion of subjectsin the categories of treatment success, treatment failure ...
View Page